DUBLIN, March 13, 2023 /PRNewswire/ — The “Medical Affairs Outsourcing Market Size, Share & Trends Analysis Report By Service (Medical Writing & Publishing, Medical Monitoring, Medical Science Liaisons, Medical Information, Others), By Industry, By Region And Segment Forecasts, 2023 – 2030” report has been added to ResearchAndMarkets.com’s offering.
The global medical affairs outsourcing market size is expected to reach USD 4.6 billion registering a CAGR of 13.6% from 2023 to 2030.
Transformation in the medical education and the rising number of orphan therapies for treatment of rare diseases are some of the key factors propelling the market growth. The pharmaceutical companies are looking for assistance to systematically position the therapeutic outcomes of these therapies in the market.
During the year 2021, the Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) approved 50 new molecular entities, of which more than half (26) were orphan drugs. A growing number of orphan drug approvals is expected to drive the global market for medical affairs outsourcing over the forecast period.
Changes in the reimbursement scenario and pricing pressure are expected to increase the adoption of cost-saving measures by the pharmaceutical and medical device companies. This is anticipated to promote off-shoring of medical affairs outsourcing in countries like India and China. Pharmaceutical companies are outsourcing medical affairs services to get high-quality documents, control the R&D cost, and reduce investment costs required to train the medical affairs team. Furthermore, pharmaceutical and medical device companies are outsourcing their medical affairs services to diverge their business activities and manage product life cycles.
In addition, Contract Research Organizations (CROs) offer cost-efficient solutions and compliance with the health authority requirements, thereby propelling market growth. The bio/pharmaceutical outsourcing industry has seen a rise in R&D demand because of the COVID-19 pandemic.
This increase in demand, as well as other impacts from the pandemic, such as rising demand for clinical trials and its outsourcing services, have caused some CROs to shift focus and adjust their operations. The pandemic has pushed more pharmaceutical companies and regulators to use new technologies for remote quality audits and inspections, thus driving positive changes in the pharma industry. Also, digitalization has for clinical trials that requires interactions with patient groups, and role in specialty care are expected to become integral to the medical affairs function and reduce the impact of pandemic.
Medical Affairs Outsourcing market Report Highlights
- The medical writing & publishing segment led the market in 2022 and is expected to witness significant growth over the forecast period, owing to the increasing need for marketable written content to convey medical information to healthcare professionals and patients.
- North America dominated the global market with a share of 34.9% in 2022 owing to the presence of a large number of pharmaceutical and medical devices companies in the region.
- Moreover, the high cost of medical affairs services is a major challenge, which has encouraged various medical device companies in North America to outsource functions to third-party vendors in off-shore locations with a high level of expertise in the domain.
- However, Asia Pacific is anticipated to grow at the fastest CAGR over the forecast period, owing to cost-efficient service offering by the CROs in the region. In addition, improved regulatory framework and availability of a skilled workforce in APAC boosts the market growth.
Key Topics Covered:
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
Chapter 3 Medical Affairs Outsourcing Market: Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Ancillary market outlook
3.2 Market Dynamics
3.2.1 Market Driver Analysis
188.8.131.52 Increasing number of clinical trials
184.108.40.206 Cost-effectiveness and high quality services offered by CROs
220.127.116.11 Stringent regulatory scenario
3.2.2 Market Restraint Analysis
18.104.22.168 Inability to hire experienced technical staff
3.2.3 Industry Challenges
22.214.171.124 Managing relationships
Chapter 4 Medical Affairs Outsourcing Market: Services Segment Analysis
4.1 Medical Affairs Outsourcings: Market Share Analysis, 2022 & 2030
4.2 Medical Writing & Publishing
4.3 Medical Monitoring
4.4 Medical Science Liaisons (MSLs)
4.5 Medical Information
Chapter 5 Medical Affairs Outsourcing Market: Industry Segment Analysis
5.1 Medical Affairs Outsourcings: Market Share Analysis, 2022 & 2030
5.4 Medical Devices
5.4.2 Therapeutic Medical Devices
5.4.3 Diagnostic Medical Devices
Chapter 6 Medical Affairs Outsourcing Market: Regional Analysis
Chapter 7 Company Profiles
- ICON plc
- THE MEDICAL AFFAIRS COMPANY
- Syneos Health
- Thermo Fischer Scientific Inc. (PPD)
- Ashfield Healthcare
- ZEINCRO Group
- Wuxi AppTec
- SGS SA
For more information about this report visit https://www.researchandmarkets.com/r/mh5kx
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Originally published at https://www.prnewswire.com/news-releases/medical-affairs-outsourcing-global-market-report-2023-increasing-number-of-clinical-trials-fuels-growth-301770438.html